Sign Out
Azmasol (Salbutamol) inhaler is indicated for the treatment and prophylaxis of bronchial asthma and for the treatment of reversible airways obstruction associated with bronchitis and emphysema. Azmasol (Salbutamol) inhaler may be used to relieve attacks of acute dyspnoea and may also be taken prophylactically before exertion or to prevent exercise-induced asthma.
It is suitable for treating bronchospasm in patients with coexisting heart disease or hypertension, including those taking beta-blockers, because of its selective action on the bronchial receptors and lack of effects on the cardiovascular system. Salbutamol is a sympathomimetic agent which has a highly selective action on beta-adrenergic receptors in bronchial muscle. At therapeutic levels, it has little effect on cardiac receptors.
